Provided by Tiger Trade Technology Pte. Ltd.

vTv Therapeutics

31.18
+1.103.66%
Post-market: 31.180.00000.00%16:10 EDT
Volume:12.84K
Turnover:394.00K
Market Cap:122.79M
PE:-29.53
High:31.18
Open:30.16
Low:30.10
Close:30.08
52wk High:44.00
52wk Low:19.50
Shares:3.94M
Float Shares:2.42M
Volume Ratio:0.49
T/O Rate:0.53%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0558
EPS(LYR):-3.2022
ROE:-15.80%
ROA:-10.14%
PB:5.76
PE(LYR):-9.74

Loading ...

vTv Therapeutics Study Finds 54% of T1D Adults on Automated Insulin Delivery Report Hypoglycemia-Related Burdens

Reuters
·
Oct 10

vTv Therapeutics Announces Oral Presentation at Breakthrough T1d Clinical and Research Congress 2026

THOMSON REUTERS
·
Oct 10

vTv Therapeutics Announces Oral Presentation at Breakthrough T1D Clinical and Research Congress 2026

GlobeNewswire
·
Oct 10

VTv Therapeutics Gets FDA Orphan Drug Designation for Sickle Cell Candidate

MT Newswires Live
·
Oct 08

vTv Therapeutics Announces FDA Orphan Drug Designation for Hppd in Sickle Cell Disease

THOMSON REUTERS
·
Oct 08

vTv Therapeutics Announces FDA Orphan Drug Designation for HPPD in Sickle Cell Disease

GlobeNewswire
·
Oct 08

vTv Therapeutics Adds Federal Forum Clause for Securities Act Claims in Bylaw Update

Reuters
·
Oct 07

vTv Therapeutics to Host Virtual KOL Event on Hypoglycemia in Type 1 Diabetes, Cadisegliatin Phase 3 Program

Reuters
·
Oct 06

vTv Therapeutics: Buy Rating Reiterated as CATT1 Phase 3 Enrollment Completed; $60 Price Target Maintained

TIPRANKS
·
Oct 06

vTv Therapeutics Announces Completion of Enrollment in Phase 3 Catt1 Study of Cadisegliatin in Type 1 Diabetes (T1d)

THOMSON REUTERS
·
Oct 05

H.C. Wainwright Sticks to Its Buy Rating for vTv Therapeutics (VTVT)

TIPRANKS
·
Sep 22

vTv Therapeutics Grants 2,500 Inducement Stock Options Priced at $31.44 Each

Reuters
·
Sep 16

vTv Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

THOMSON REUTERS
·
Sep 16

vTv Therapeutics to Participate in September Investor Conferences

GlobeNewswire
·
Sep 02

vTv Therapeutics initiated with an Outperform at LifeSci Capital

TIPRANKS
·
Sep 02

vTv Therapeutics Grants 2,500 Inducement Stock Options Priced at $31.48 Per Share

Reuters
·
Aug 20

Press Release: vTv Therapeutics Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Dow Jones
·
Aug 20

vTv Therapeutics Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 10

Analysts Conflicted on These NA Names: LATAM Airlines Group SA Sponsored ADR (LTM), vTv Therapeutics (VTVT) and Once Upon a Farm, PBC (OFRM)

TIPRANKS
·
Aug 10

vTv Therapeutics Inc Expected to Post a Loss of $1.04 a Share - Earnings Preview

Reuters
·
Aug 07